栄養補助食品グミ市場規模、シェア、動向、2030年までの世界予測

栄養補助食品グミ市場は、2025年には243億9,000万米ドルに達すると推定され、2030年には478億米ドルに達し、年平均成長率（CAGR）14.4%で成長すると予測されています。世界の栄養補助食品グミ市場は、ビタミン欠乏症や栄養不足の増加、予防的な健康とウェルネスへの関心の高まり、美容とウェルネスへの消費者の関心の高まり、eコマースとDTCチャネルの拡大、そして従来の錠剤やカプセルよりもグミによる提供形態が好まれる傾向に牽引され、大幅な成長を遂げています。さらに、植物由来および無糖グミの成長、スタートアップ企業やD2Cブランドによるターンキー契約製造への依存度の高まり、そして地域特有の製剤専門知識を活用した地理的拡大により、栄養補助食品グミ市場に大きなビジネスチャンスが創出されると予想されています。

しかし、高い生産コストと原料の安定性の問題、地域間の規制の複雑さ、そしてバッチ間の一貫性と安定性の維持の複雑さは、栄養補助食品グミ市場において課題となることが予想されます。さらに、世界的なブランドオーナーからの監査要求の高まり、熾烈な市場競争、そしてブランドの差別化も、依然として技術的な課題となっています。

調査対象範囲

本調査レポートでは、栄養補助食品グミ市場を、タイプ（B2B市場およびB2C市場）、顧客タイプ（B2B）（ブランド所有者およびマーケティング会社、小売業者および販売業者、ヘルスケアおよびウェルネスプロバイダー、製薬会社、食品および飲料会社）、生産能力（B2B）（小規模契約メーカー（年間1,000万個未満）、中規模メーカー（年間1,000万～5,000万個）、大規模産業メーカー（年間5,000万個以上））、原料ソース（B2B）（動物由来、植物由来、微生物/発酵由来、合成/化学由来）、グミベース/賦形剤（B2B）（ゼラチンベースのグミ、ペクチンベースのグミ、デンプンベースのグミ、寒天、カラギーナン、その他のハイドロコロイド）で分類しています。製品タイプ（B2C）（ビタミン、ミネラル、オメガ3脂肪酸、プロバイオティクスとプレバイオティクス、コラーゲンと内側からの美しさ、ハーブと植物性サプリメント、食物繊維、CBDと大麻由来、および特殊製剤）; 機能性（B2C）（免疫サポート、一般的な健康とウェルネス、骨と関節の健康、体重管理、美容と肌の健康、およびその他の機能）; 人口統計（B2C）（アルファ世代（0～12歳）、Z世代（13～28歳）、ミレニアル世代（Y世代）（29～44歳）、X世代（45～60歳）、およびベビーブーマー世代以上（61歳以上）、販売チャネル（オフラインおよびオンライン）、地域（北米、ヨーロッパ、アジア太平洋、南米、その他の国）です。

本レポートは、栄養補助食品グミ業界の成長に影響を与える主要な要因（促進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーを徹底的に分析し、各社の事業、サービス、主要戦略、契約、パートナーシップ、合意、製品発売、合併・買収、そして栄養補助食品グミ市場における最近の動向に関する洞察を提供しています。本レポートは、栄養補助食品グミ市場エコシステムにおける新興スタートアップ企業の競争力分析を提供しています。さらに、技術分析、エコシステムと市場のマッピング、特許と規制の状況など、業界固有のトレンドも網羅しています。

このレポートを購入する理由

本レポートは、市場リーダー企業および新規参入企業に対し、栄養補助食品グミ全体とそのサブセグメントの収益数値に関する近似値に関する情報を提供します。これにより、関係者は競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めることができます。また、本レポートは、市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供することで、関係者の理解を深めるのに役立ちます。

本レポートでは、以下の点について洞察を提供しています。

• 栄養補助食品グミ市場の成長に影響を与える主要な推進要因（従来の錠剤やカプセルよりもグミの投与形態への嗜好の高まり、生産量の押し上げ）、制約要因（原料調達の不安定さ）、機会（スタートアップ企業やD2Cブランドのターンキー契約製造への依存度の高まり）、課題（グローバルブランドオーナーによる監査への期待の高まり）の分析
• 製品開発／イノベーション：栄養補助食品グミ市場における研究開発活動と新製品の発売に関する詳細な洞察
• 市場開発：収益性の高い市場に関する包括的な情報 – 様々な地域における栄養補助食品グミの分析
• 市場の多様化：栄養補助食品グミ市場における新製品の供給源、未開拓地域、最近の動向、投資に関する網羅的な情報
• 競合評価：ブランドメーカー：Church & Dwight Co., Inc.（米国）、H&H Group（香港）、Amway（米国）、Bayer AG（ドイツ）、Haleon（英国）、Nestlé（スイス）、Unilever（米国）、大塚ホールディングス株式会社（日本）、PharmaCare Laboratories Australia（オーストラリア）、Swanson（米国）、IM Healthcare（インド）、SMP Nutra（米国）、Nature’s Truth（米国）、Herbaland Naturals Inc.（カナダ）、契約メーカー：Sofgen Pharma（ルクセンブルク）、Catalent, Inc.（米国）、Activ’Inside（フランス）、WinNutra（米国）、Makers Nutrition, LLC（米国）、Ion Labs（米国）、Vitajoy Group（中国）、Bliss Lifesciences LLP（インド）などの主要プレーヤーの市場シェア、成長戦略、製品提供、ブランド/製品比較、製品フットプリントの詳細な評価。栄養補助食品グミ市場の他のプレーヤーとしては、Global Widget, LLC (米国)、Gummy Worlds (トルコ)、TopGum (イスラエル)、MeriCal (米国)、Fexmentis Life Sciences (インド)、Eagle Labs, Inc. (米国) などがあります。

Report Description

The nutraceutical gummies market is estimated at USD 24.39 billion in 2025 and is projected to reach USD 47.80 billion by 2030, at a CAGR of 14.4%. The global nutraceutical gummies market is experiencing significant growth, driven by rising rates of vitamin deficiency and undernutrition, a growing focus on preventive health and wellness, rising consumer interest in beauty and wellness, expanding e-commerce and DTC channels, and an increasing preference for the gummy delivery format over traditional pills and capsules. Additionally, growth in plant-based and sugar-free gummies, increasing reliance of startups and D2C brands on turnkey contract manufacturing, and geographic expansion with localized formulation expertise are expected to create significant opportunities in the nutraceutical gummies market.

However, high production costs and ingredient stability issues, regulatory complexities across regions, and the complexity of maintaining batch-to-batch consistency and stability are expected to pose challenges in the nutraceutical gummies market. Furthermore, increasing audit expectations from global brand owners and intense market competition and brand differentiation also remain technical challenges.

“Immunity support function is expected to hold a dominant market share during the forecast period.”

The popularity of nutraceutical gummies is growing because of their convenient form, size, and ease of consumption. The benefits of multivitamin gummies for boosting immunity also play a key role in the increased demand for nutraceutical gummies. Gummies offer the fastest growth potential for vitamin and mineral supplements. The market for immunity-specific gummy supplements is expected to grow as more people become aware of how nutrition affects their health and of the specific issues that can be addressed through lifestyle factors.

“The online channel segment in the B2C segment is expected to hold a significant market share among the sales channels in the nutraceutical gummies market.”

With rising awareness, demand, and traction, nutraceutical gummies have become a mainstream market staple. The increase in demand for these products has led to a rise in sales across various countries and regions, facilitated by both online and offline distribution channels. Key players are increasingly adopting and navigating their investments in distribution channels to make their products available to a wider consumer base. In addition, nutraceutical gummies manufacturing companies are promoting their products in the market through strategies such as online retailing, a part of the non-store-based distribution channel, which is expected to drive demand.

“Europe is expected to hold a significant share in the global nutraceutical gummies market during the forecast period.”

Companies operating in this region are also investing in expansions and acquisitions to meet the growing demand from the dietary supplements industry, including nutraceutical gummies. The growing demand for nutraceutical gummies in Europe is attributed to fast-paced lifestyles, health-conscious consumers, and urbanization. In 2020, Unilever acquired SmartyPants Vitamins, a US-based vitamin, mineral & supplement company. SmartyPants utilizes a range of sustainably sourced, bioavailable nutrients and non-GMO-certified ingredients. Its product line is free of artificial preservatives, sweeteners, colors, and flavors. This has made Unilever expand its product portfolio and serve more consumers in Europe.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the nutraceutical gummies market.

• By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
• By Designation: CXOs – 25%, Managers – 40%, Others – 35%
• By Region: North America – 25%, Europe – 25%, Asia Pacific – 35%, South America – 10%, and Rest of the World –5%

Prominent companies in the market include—Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestlé (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature’s Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. ( US),  Activ’Inside ( France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US) among others.

Research Coverage

This research report categorizes the nutraceutical gummies market by type (B2B market and B2C market); customer type (B2B) (brand owners and marketing companies, retailers and distributors, healthcare and wellness providers, pharmaceutical companies, and food & beverage companies); production capacity (B2B) (small-scale contract manufacturers (< 10 m units/year), mid-scale manufacturers (10–50 m units/year), and large-scale industrial manufacturers (50 m+ units/year)); ingredient source (B2B) (animal-based source, plant-based source, microbial/fermentation-derived sources, and synthetic/chemically-derived sources); gummy base/excipients (B2B) (gelatin-based gummies, pectin-based gummies, starch-based gummies, agar, carrageenan, and other hydrocolloids); product type (B2C) (vitamins, minerals, omega-3 fatty acids, probiotics and prebiotics, collagen and beauty-from-within, herbal and botanical supplements, dietary fiber, CBD and cannabis-derived, and specialty formulations); functionality (B2C) (immunity support, general health & wellness, bone & joint health, weight management, beauty & skin health, and other functionalities); demographics (B2C) (generation alpha (0–12 years), generation Z (13–28 years), millennials (gen Y) (29–44 years), generation X (45–60 years), and baby boomers & older (61+ years)); sales channel (offline and online); and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical gummies industry. A thorough analysis of key industry players has been conducted to provide insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments in the nutraceutical gummies market. This report provides a competitive analysis of emerging startups in the nutraceutical gummies market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical gummies and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (increasing preference for gummy delivery format over traditional pills and capsules, driving production volume), restraints (ingredient sourcing volatility), opportunities (increasing reliance of startups and D2C brands on turnkey contract manufacturing), and challenges (increasing audit expectations from global brand owners), influencing the growth of the nutraceutical gummies market
• Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical gummies market
• Market Development: Comprehensive information about lucrative markets—analysis of nutraceutical gummies across varied regions
• Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the nutraceutical gummies market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestlé (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature’s Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. (US), Activ’Inside (France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US), among other players in the nutraceutical gummies market.

Table of Contents

1 INTRODUCTION 49
1.1 STUDY OBJECTIVES 49
1.2 MARKET DEFINITION 49
1.2.1 INCLUSIONS AND EXCLUSIONS 50
1.3 STUDY SCOPE 52
1.4 YEARS CONSIDERED 53
1.5 CURRENCY CONSIDERED 53
1.6 UNIT CONSIDERED 54
1.7 STAKEHOLDERS 54
2 EXECUTIVE SUMMARY 55
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 55
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 57
2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL GUMMIES MARKET 58
2.4 HIGH GROWTH SEGMENTS 59
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 60
3 PREMIUM INSIGHTS 61
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET 61
3.2 B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY AND REGION 62
3.3 B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE AND REGION 63
3.4 B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE 63
3.5 B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE 64
3.6 B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS 64
3.7 B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY 65
3.8 B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY 65
4 MARKET OVERVIEW 66
4.1 INTRODUCTION 66
4.2 MARKET DYNAMICS 67
4.2.1 DRIVERS 67
4.2.1.1 Rising rate of vitamin-deficiency diseases and undernutrition 67
4.2.1.2 Growing consumer interest in beauty and wellness 68
4.2.1.3 Innovation in functional formulations 69
4.2.1.4 Growth in gummy supplement launches and custom gummy programs 70
4.2.1.5 Increasing preference for gummy delivery format over traditional pills and capsules 70

4.2.2 RESTRAINTS 71
4.2.2.1 Regulatory complexities across regions 71
4.2.2.2 Sugar content and health concerns 71
4.2.2.3 Ingredient sourcing volatility 72
4.2.2.4 Complexity in maintaining batch-to-batch consistency and stability 72
4.2.3 OPPORTUNITIES 72
4.2.3.1 Rising popularity of plant-based and sugar-free gummies 72
4.2.3.2 Expansion into personalized and AI-driven nutrition 73
4.2.3.3 Increasing reliance of startups and D2C brands on turnkey contract manufacturing 73
4.2.3.4 Geographic expansion with localized formulation expertise 74
4.2.4 CHALLENGES 74
4.2.4.1 Limited bioavailability and nutrient degradation 74
4.2.4.2 Intense market competition and brand differentiation 75
4.2.4.3 Logistics issues: Melting, deformation, and transit stability 75
4.2.4.4 Increasing audit expectations from global brand owners 75
4.3 UNMET NEEDS AND WHITE SPACES 76
4.3.1 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET 76
4.3.2 WHITE SPACE OPPORTUNITIES 77
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 78
4.4.1 INTERCONNECTED MARKETS 78
4.4.2 CROSS-SECTOR OPPORTUNITIES 79
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 80
4.5.1 KEY MOVES AND STRATEGIC FOCUS 80
5 INDUSTRY TRENDS 81
5.1 PORTER’S FIVE FORCES ANALYSIS 81
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 82
5.1.2 BARGAINING POWER OF SUPPLIERS 82
5.1.3 BARGAINING POWER OF BUYERS 82
5.1.4 THREAT OF SUBSTITUTES 82
5.1.5 THREAT OF NEW ENTRANTS 82
5.2 MACROECONOMICS OUTLOOK 83
5.2.1 INTRODUCTION 83
5.2.1.1 Macroeconomic indicators – B2C market 83
5.2.1.1.1 US-China trade tariff fluctuations reshape nutraceutical gummies market 83
5.2.1.1.2 Inflation and raw material costs reshape nutraceutical gummies market 84
5.2.1.1.2.1 Sweeteners and sugar inputs 84
5.2.1.1.2.2 Gelling agents: Gelatin, pectin, and alternatives 84
5.2.1.1.2.3 Vitamins, actives, flavors, and specialty additives 84
5.2.1.1.2.4 Energy, transportation, and packaging inflation 85
5.2.1.2 Macroeconomic indicators – B2B market 85
5.2.1.2.1 Population aging and chronic disease burden influencing preventive health and nutraceutical market expansion 85
5.3 VALUE CHAIN ANALYSIS 86
5.3.1 RAW MATERIAL & FUNCTIONAL INGREDIENT SOURCING 87
5.3.2 PRODUCT DEVELOPMENT AND MANUFACTURING 88
5.3.3 QUALITY, SAFETY, AND REGULATORY COMPLIANCE 88
5.3.4 PACKAGING & LABEL CUSTOMIZATION 89
5.3.5 MARKETING AND DISTRIBUTION 89
5.3.6 END USERS 89
5.4 ECOSYSTEM ANALYSIS 89
5.4.1 DEMAND SIDE 89
5.4.2 SUPPLY SIDE 90
5.5 PRICING ANALYSIS 91
5.5.1 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES,
BY KEY PLAYER 91
5.5.2 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES,
BY REGION 94
5.6 TRADE ANALYSIS 96
5.6.1 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY,
2020–2024 (MT) 96
5.6.2 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY,
2020–2024 (MT) 96
5.7 KEY CONFERENCES AND EVENTS, 2026–2027 98
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 99
5.9 INVESTMENT AND FUNDING SCENARIO 99
5.10 CASE STUDY ANALYSIS 100
5.10.1 NESTLÉ HEALTH SCIENCE – EXPANDED COLLAGEN & FUNCTIONAL PORTFOLIO THROUGH MAJORITY STAKE ACQUISITION OF VITAL PROTEINS 100
5.10.2 SIRIO PHARMA – EXPANDING NUTRACEUTICAL GUMMY AND PLANT-BASED SOFTGEL MANUFACTURING THROUGH ACQUISITION OF BEST FORMULATIONS 100
5.10.3 TOPGUM INDUSTRIES – EXPANDING PHARMA GRADE AND HIGH VOLUME GUMMY MANUFACTURING THROUGH ACQUISITION OF ISLAND ABBEY NUTRITIONALS 101
5.10.4 GILLCO/IFF GRINDSTED – ENHANCING GUMMY GELATION AND PROCESS STABILITY USING SLOW-SET PECTIN 102
5.11 IMPACT OF 2025 US TARIFF – NUTRACEUTICAL GUMMIES MARKET 102
5.11.1 INTRODUCTION 102
5.11.2 KEY TARIFF RATES 103
5.11.3 PRICE IMPACT ANALYSIS 104
5.11.4 IMPACT ON COUNTRIES/REGIONS 104
5.11.4.1 US 104
5.11.4.2 Europe 105
5.11.4.3 Asia Pacific 105
5.11.5 IMPACT ON END-USE INDUSTRIES 105
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 107
6.1 TECHNOLOGY ANALYSIS 107
6.1.1 KEY TECHNOLOGIES 107
6.1.1.1 Gelling and texture technology 107
6.1.1.1.1 Starch-based gelling technology 108
6.1.1.1.2 Starchless gelling technology 108
6.1.1.2 Microencapsulation technology (taste masking & flavor) 108
6.1.2 COMPLEMENTARY TECHNOLOGIES 109
6.1.2.1 Coating technology 109
6.1.2.2 Nutrient stabilization methods 109
6.1.2.3 Flavor release systems 110
6.1.3 ADJACENT TECHNOLOGIES 110
6.1.3.1 3D-printing & personalized dosing platforms 110
6.1.3.2 Plant-based and clean-label ingredient technologies 110
6.1.3.3 Smart packaging 111
6.2 TECHNOLOGY/PRODUCT ROADMAP 111
6.2.1 SHORT-TERM | FOUNDATION & EARLY COMMERCIALIZATION 111
6.2.2 MID-TERM | EXPANSION & STANDARDIZATION 112
6.2.3 LONG-TERM | PRECISION NUTRITION & SMART CALCIUM SOLUTIONS 112
6.3 PATENT ANALYSIS 112
6.4 FUTURE APPLICATIONS 114
6.4.1 GELATIN-FREE, REDUCED-SUGAR FUNCTIONAL GUMMIES ENRICHED WITH PGH EXTRACT 114
6.4.2 MICROENCAPSULATION OF VITAMIN C FOR IMPROVED STABILITY IN NUTRACEUTICAL GUMMIES 115
6.4.3 3D-PRINTED PATIENT-TAILORED MEDICINAL GUMMIES FOR PEDIATRIC DRUG DELIVERY 115
6.4.4 EDIBLE ACTIVE PACKAGING AS SMART PACKAGING FOR NUTRACEUTICAL GUMMIES 116
6.4.5 IOT-ENABLED SMART MANUFACTURING AND ITS FUTURE APPLICATION IN NUTRACEUTICAL GUMMY PRODUCTION 117
6.5 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 117
6.5.1 INTRODUCTION 117
6.5.2 USE OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 118
6.5.3 TOP USE CASES AND MARKET POTENTIAL 118
6.5.4 BEST PRACTICES IN NUTRACEUTICAL INDUSTRY 119
6.5.5 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL GUMMIES MARKET 119
6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 120
6.5.7 CLIENTS’ READINESS TO ADOPT GENERATIVE AI NUTRACEUTICAL GUMMIES 120
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 121
7.1 REGIONAL REGULATIONS AND COMPLIANCE 121
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
7.1.2 INDUSTRY STANDARDS 123
7.1.3 LABELING REQUIREMENTS AND CLAIMS 124
7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5–10 YEARS 125
7.1.4.1 Mandatory validation of bioavailability & functional claims 125
7.1.4.2 Global harmonization of dietary supplement & nutraceutical classifications 125
7.1.4.3 Strengthened safety, contaminant, & additive control regulations 125
7.1.4.4 Digital labeling, traceability & QR-based compliance tracking 125
7.2 SUSTAINABILITY INITIATIVES 126
7.2.1 SUSTAINABLE SOURCING 126
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 126
7.2.3 CIRCULAR ECONOMY APPROACHES 127
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 127
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 128
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 129
8.1 DECISION-MAKING PROCESS 129
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 130
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 130
8.2.2 BUYING CRITERIA 131
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 132
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 133
8.5 MARKET PROFITABILITY 134
8.6 REVENUE POTENTIAL 134
8.6.1 COST DYNAMICS 135
8.6.2 MARGIN OPPORTUNITIES, BY TYPE 136
9 NUTRACEUTICAL GUMMIES MARKET, BY TYPE 137
9.1 INTRODUCTION 138
9.2 B2C MARKET 139
9.2.1 ADVANCING CONSUMER HEALTH THROUGH FUNCTIONAL GUMMIES 139
9.3 B2B MARKET 139
9.3.1 POWERING BRANDS WITH SCALABLE, SCIENCE-DRIVEN GUMMY SOLUTIONS 139
10 NUTRACEUTICAL GUMMIES MARKET (B2B), BY CUSTOMER TYPE 140
10.1 INTRODUCTION 141
10.2 BRAND OWNERS & MARKETING COMPANIES 142
10.2.1 DEMAND FOR DIFFERENTIATED, CLEAN-LABEL, AND TREND-RESPONSIVE GUMMY FORMULATIONS TO BENEFIT CONTRACT MANUFACTURERS AND PRIVATE-LABEL PARTNERS 142
10.3 RETAILERS & DISTRIBUTORS 145
10.3.1 RAPID EXPANSION OF PRIVATE-LABEL SUPPLEMENTS AND OMNICHANNEL RETAIL STRATEGIES TO INCREASE RETAILER DEMAND FOR COST-EFFICIENT, HIGH-QUALITY GUMMY MANUFACTURING PARTNERSHIPS 145
10.4 HEALTHCARE & WELLNESS 147
10.4.1 GROWING INTEGRATION OF NUTRITION INTO PREVENTIVE CARE, PEDIATRICS, AND WELLNESS PROGRAMS TO DRIVE DEMAND FOR CLINICALLY CREDIBLE, COMPLIANCE-FRIENDLY GUMMY SUPPLEMENTS 147
10.5 PHARMACEUTICAL COMPANIES 149
10.5.1 PHARMACEUTICAL PLAYERS LEVERAGE NUTRACEUTICAL GUMMIES TO EXTEND CONSUMER HEALTH PORTFOLIOS BEYOND PRESCRIPTIONS WHILE MAINTAINING CLINICAL CREDIBILITY AND QUALITY DIFFERENTIATION 149
10.6 FOOD & BEVERAGE COMPANIES 151
10.6.1 CONVERGENCE OF INDULGENCE AND FUNCTIONALITY PROMPTING CONFECTIONERY AND FOOD COMPANIES TO EXPLORE FUNCTIONAL GUMMIES 151
11 NUTRACEUTICAL GUMMIES MARKET (B2B), BY PRODUCTION CAPACITY 154
11.1 INTRODUCTION 155
11.2 SMALL-SCALE CONTRACT MANUFACTURERS (<10 M UNITS/YEAR) 156
11.2.1 GROWING DEMAND FOR LOW-VOLUME, CUSTOMIZED GUMMY FORMULATIONS TO SUPPORT EMERGING NUTRACEUTICAL BRANDS 156
11.3 MID-SCALE MANUFACTURERS (10–50 M UNITS/YEAR) 157
11.3.1 INCREASING NEED FOR SCALABLE PRODUCTION WITH FORMULATION FLEXIBILITY TO SUPPORT BRAND EXPANSION AND REGIONAL MARKET PENETRATION 157
11.4 LARGE-SCALE INDUSTRIAL MANUFACTURERS (50+ M UNITS/YEAR) 159
11.4.1 RISING REQUIREMENT FOR HIGH-VOLUME, STANDARDIZED GUMMY PRODUCTION TO ENSURE SUPPLY CONSISTENCY FOR GLOBAL NUTRACEUTICAL BRANDS 159
12 NUTRACEUTICAL GUMMIES MARKET (B2B), BY INGREDIENT SOURCE 161
12.1 INTRODUCTION 162
12.2 ANIMAL-BASED SOURCES 163
12.2.1 COLLAGEN EFFICACY KEEPS ANIMAL-BASED INGREDIENTS DOMINANT 163
12.3 PLANT-BASED SOURCES 165
12.3.1 VEGAN AND CLEAN-LABEL DEMAND FUELS PLANT-BASED ADOPTION 165
12.4 MICROBIAL/FERMENTATION-DERIVED SOURCES 167
12.4.1 ADVANCEMENTS IN STABILIZED FERMENTATION TECHNOLOGIES TO EXPANDING ADOPTION OF MICROBIAL-DERIVED ACTIVES IN GUMMY FORMULATIONS 167
12.5 SYNTHETIC/CHEMICALLY-DERIVED SOURCES 169
12.5.1 CONSISTENCY AND SCALE TO SUSTAIN SYNTHETIC INGREDIENT USAGE 169
13 NUTRACEUTICAL GUMMIES MARKET (B2B), BY GUMMY BASE/EXCIPIENTS 172
13.1 INTRODUCTION 173
13.2 GELATIN-BASED GUMMIES 174
13.2.1 HIGH ACTIVE LOADING AND TEXTURE RELIABILITY TO CONTINUE DRIVING GELATIN USAGE 174
13.3 PECTIN-BASED GUMMIES 175
13.3.1 VEGAN POSITIONING AND CLEAN-LABEL DEMAND TO ACCELERATE PECTIN ADOPTION 175
13.4 STARCH-BASED GUMMIES 176
13.4.1 COST PRESSURE AND LARGE-SCALE PRODUCTION NEEDS TO SUSTAIN STARCH-BASED SYSTEMS 176
13.5 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS 177
14 NUTRACEUTICAL GUMMIES MARKET (B2C), BY PRODUCT TYPE 179
14.1 INTRODUCTION 180
14.2 VITAMINS 181
14.2.1 RISING INSTANCES OF VITAMIN DEFICIENCIES TO DRIVE SEGMENT 181
14.2.2 MULTIVITAMINS 183
14.2.3 VITAMIN C 184
14.2.4 VITAMIN D 185
14.2.5 VITAMIN B COMPLEX 186
14.2.6 VITAMIN E AND A 187
14.3 MINERALS 189
14.3.1 MEETING ESSENTIAL MINERAL NEEDS THROUGH CONVENIENT, PALATABLE SUPPLEMENTATION FOR EVERYDAY HEALTH SUPPORT 189
14.3.2 CALCIUM 191
14.3.3 IRON 191
14.3.4 ZINC 192
14.3.5 MAGNESIUM 193
14.4 OMEGA-3 FATTY ACIDS 194
14.5 PROBIOTICS & PREBIOTICS 196
14.5.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET 196
14.6 COLLAGEN & BEAUTY-FROM-WITHIN 197
14.6.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET 197
14.7 HERBAL & BOTANICAL 199
14.7.1 RISING CONSUMER PREFERENCE FOR PLANT-BASED NATURAL INGREDIENTS TO DRIVE SEGMENT 199
14.7.2 ASHWAGANDHA 201
14.7.3 TURMERIC/CURCUMIN 202
14.7.4 ELDERBERRY 203
14.7.5 MELATONIN 204
14.7.6 OTHER HERBAL AND BOTANICAL GUMMIES 205
14.8 DIETARY FIBER 205
14.9 CBD & CANNABIS-DERIVED 206
14.10 SPECIALTY FORMULATIONS 208
14.10.1 HEALTH-PROMOTING PROPERTIES TO AUGMENT SEGMENT GROWTH 208
15 NUTRACEUTICAL GUMMIES MARKET(B2C), BY FUNCTIONALITY 209
15.1 INTRODUCTION 210
15.2 IMMUNITY SUPPORT 211
15.2.1 RISING FOCUS ON IMPROVING IMMUNITY TO DRIVE MARKET 211
15.3 GENERAL HEALTH & WELLNESS 212
15.3.1 GROWING NUTRITIONAL DEFICIENCIES AND PREVENTIVE HEALTHCARE TRENDS TO DRIVE MARKET 212
15.4 BONE & JOINT HEALTH 213
15.4.1 RISING CASES OF OSTEOPOROSIS TO PROPEL MARKET GROWTH 213
15.5 WEIGHT MANAGEMENT 215
15.5.1 RISING PREVALENCE OF OBESITY AND METABOLIC DISORDERS TO DRIVE MARKET 215
15.6 BEAUTY & SKIN HEALTH 216
15.6.1 INCREASING FOCUS ON APPEARANCE AND OVERALL SKIN WELLNESS TO DRIVE MARKET 216
16 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DEMOGRAPHICS 219
16.1 INTRODUCTION 220
16.2 GENERATION ALPHA (0–12 YEARS) 221
16.2.1 EARLY-LIFE SUPPLEMENTATION AND DIGITAL-FIRST PARENTING TO FUEL DEMAND FOR PEDIATRIC NUTRACEUTICAL GUMMIES 221
16.3 GENERATION Z (13–28 YEARS) 222
16.3.1 FOCUS ON HEALTH AND DAILY SELF-CARE TO FUEL GUMMY SUPPLEMENT DEMAND 222
16.4 MILLENNIALS (GEN Y) (29–44 YEARS) 224
16.4.1 LIFESTYLE-DRIVEN WELLNESS CHOICES TO POWER NUTRACEUTICAL ADOPTION 224
16.5 GENERATION X (45–60 YEARS) 225
16.5.1 WILLINGNESS TO INVEST IN HEALTH-ENHANCING NUTRITION SOLUTIONS TO DRIVE MARKET 225
16.6 BABY BOOMERS AND OLDER (61+ YEARS) 226
16.6.1 HEALTHY AGING PRIORITIES TO DRIVE NUTRACEUTICAL USE 226
17 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DISTRIBUTION CHANNEL 228
17.1 INTRODUCTION 229
17.2 OFFLINE CHANNELS 230
17.2.1 HYPERMARKETS & SUPERMARKETS 232
17.2.1.1 Preferred purchasing destination and availability of variants to drive growth 232
17.2.2 PHARMACIES & DRUGSTORES 233
17.2.2.1 Wide presence and around-the-clock services to drive growth 233
17.2.3 SPECIALTY HEALTH STORES 234
17.2.3.1 Enabling premium and targeted gummy supplement sales 234
17.2.4 CONVENIENCE STORES 235
17.2.4.1 Preference toward specialized healthcare products to fuel growth 235
17.2.5 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM) 236
17.2.5.1 High-volume retail and network-based selling drive offline expansion 236
17.3 ONLINE CHANNELS 237
18 NUTRACEUTICAL GUMMIES MARKET, BY REGION 239
18.1 INTRODUCTION 240
18.2 NORTH AMERICA 244
18.2.1 US 264
18.2.1.1 Presence of key players and various health trends to boost market 264
18.2.2 CANADA 267
18.2.2.1 Convenience, taste, and health benefits to drive demand for nutraceutical gummies 267
18.2.3 MEXICO 269
18.2.3.1 Rising health-conscious and vegan population to drive market 269
18.3 EUROPE 271
18.3.1 GERMANY 291
18.3.1.1 Growing interest in health & wellness to drive market 291
18.3.2 UK 293
18.3.2.1 Rising prevalence of diseases to drive market 293
18.3.3 FRANCE 296
18.3.3.1 High healthcare costs and increased demand for dietary supplements to drive market 296
18.3.4 SPAIN 298
18.3.4.1 Adoption of healthy lifestyles to drive market 298
18.3.5 ITALY 301
18.3.5.1 Strong e-commerce system and rising geriatric population to drive market 301
18.3.6 REST OF EUROPE 303
18.4 ASIA PACIFIC 305
18.4.1 CHINA 325
18.4.1.1 Large population and increasing prevalence of diseases to drive market 325
18.4.2 JAPAN 328
18.4.2.1 Rising awareness and shifting preferences toward dietary supplements to drive market 328
18.4.3 INDIA 330
18.4.3.1 Rising disposable incomes and growing focus on wellness to drive market 330
18.4.4 AUSTRALIA & NEW ZEALAND 333
18.4.4.1 High demand for dietary supplements, particularly in new formats, to drive market 333
18.4.5 REST OF ASIA PACIFIC 335
18.5 SOUTH AMERICA 338
18.5.1 BRAZIL 357
18.5.1.1 Increasing consumer preference for convenient and palatable formats in nutrient intake to drive market 357
18.5.2 ARGENTINA 360
18.5.2.1 Growing focus on prevention of micronutrient deficiencies and cardiometabolic risks to drive market 360
18.5.3 REST OF SOUTH AMERICA 362
18.6 REST OF THE WORLD 364
18.6.1 MIDDLE EAST 383
18.6.1.1 Rising disposable incomes and healthcare costs to drive market 383
18.6.2 AFRICA 386
18.6.2.1 Increase in vitamin deficiency and consumer awareness about health supplements to fuel market 386
19 COMPETITIVE LANDSCAPE 389
19.1 OVERVIEW 389
19.2 B2C PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2025 389
19.3 REVENUE ANALYSIS (B2C MARKET), 2022–2024 391
19.4 MARKET SHARE ANALYSIS (B2C MARKET), 2024 392
19.5 MARKET SHARE ANALYSIS (B2B MARKET), 2024 394
19.6 BRAND/PRODUCT COMPARISON 396
19.7 COMPANY EVALUATION MATRIX: B2C COMPANIES, 2024 397
19.7.1 STARS 398
19.7.2 EMERGING LEADERS 398
19.7.3 PERVASIVE PLAYERS 398
19.7.4 PARTICIPANTS 398
19.7.5 COMPANY FOOTPRINT: B2C NUTRACEUTICAL GUMMIES COMPANIES, 2024 400
19.7.5.1 Company footprint 400
19.7.5.2 Regional footprint 401
19.7.5.3 Product type footprint 402
19.7.5.4 Functionality footprint 403
19.8 COMPANY EVALUATION MATRIX: B2B COMPANIES, 2024 404
19.8.1 STARS 404
19.8.2 EMERGING LEADERS 404
19.8.3 PERVASIVE PLAYERS 404
19.8.4 PARTICIPANTS 405
19.8.5 COMPETITIVE BENCHMARKING 406
19.8.5.1 Detailed list of B2B key players 406
19.8.6 COMPETITIVE BENCHMARKING: B2B COMPANIES, 2024 407
19.8.6.1 Competitive benchmarking of key B2B companies 407
19.9 COMPANY VALUATION AND FINANCIAL METRICS 408
19.10 COMPETITIVE SCENARIO 409
19.10.1 PRODUCT LAUNCHES 409
19.10.2 DEALS 413
19.10.3 EXPANSIONS 416
19.10.4 OTHER DEVELOPMENTS 418
20 COMPANY PROFILES 419
20.1 B2C PLAYERS (BRAND MANUFACTURERS) 419
20.1.1 CHURCH & DWIGHT CO., INC. 419
20.1.1.1 Business overview 419
20.1.1.2 Products/Solutions/Services offered 420
20.1.1.3 Recent developments 421
20.1.1.3.1 Product launches 421
20.1.1.4 MnM view 422
20.1.1.4.1 Key strengths 422
20.1.1.4.2 Strategic choices 422
20.1.1.4.3 Weaknesses and competitive threats 422
20.1.2 H&H GROUP 423
20.1.2.1 Business overview 423
20.1.2.2 Products/Solutions/Services offered 424
20.1.2.3 Recent developments 425
20.1.2.3.1 Deals 425
20.1.2.3.2 Expansions 426
20.1.2.3.3 Other developments 426
20.1.2.4 MnM view 427
20.1.2.4.1 Key strengths 427
20.1.2.4.2 Strategic choices 427
20.1.2.4.3 Weaknesses and competitive threats 427
20.1.3 AMWAY 428
20.1.3.1 Business overview 428
20.1.3.2 Products/Solutions/Services offered 429
20.1.3.3 Recent developments 430
20.1.3.3.1 Product launches 430
20.1.3.3.2 Deals 431
20.1.3.4 MnM view 431
20.1.3.4.1 Key strengths 431
20.1.3.4.2 Strategic choices 431
20.1.3.4.3 Weaknesses and competitive threats 431

20.1.4 BAYER AG 432
20.1.4.1 Business overview 432
20.1.4.2 Products/Solutions/Services offered 433
20.1.4.3 Recent developments 435
20.1.4.3.1 Product launches 435
20.1.4.4 MnM view 435
20.1.4.4.1 Key strengths 435
20.1.4.4.2 Strategic choices 435
20.1.4.4.3 Weaknesses and competitive threats 435
20.1.5 HALEON GROUP OF COMPANIES 436
20.1.5.1 Business overview 436
20.1.5.2 Products/Solutions/Services offered 437
20.1.5.3 Recent developments 439
20.1.5.3.1 Product launches 439
20.1.5.3.2 Deals 440
20.1.5.3.3 Expansions 440
20.1.5.4 MnM view 440
20.1.5.4.1 Key strengths 440
20.1.5.4.2 Strategic choices 441
20.1.5.4.3 Weaknesses and competitive threats 441
20.1.6 NESTLE 442
20.1.6.1 Business overview 442
20.1.6.2 Products/Solutions/Services offered 443
20.1.6.3 Recent developments 445
20.1.6.3.1 Product launches 445
20.1.6.3.2 Deals 445
20.1.6.4 MnM view 446
20.1.6.4.1 Key strengths 446
20.1.6.4.2 Strategic choices 446
20.1.6.4.3 Weaknesses and competitive threats 446
20.1.7 UNILEVER 447
20.1.7.1 Business overview 447
20.1.7.2 Products/Solutions/Services offered 448
20.1.7.3 Recent developments 449
20.1.7.3.1 Product launches 449
20.1.7.3.2 Deals 449
20.1.7.3.3 Expansions 450
20.1.7.4 MnM view 450
20.1.7.4.1 Key strengths 450
20.1.7.4.2 Strategic choices 450
20.1.7.4.3 Weaknesses and competitive threats 450

20.1.8 OTSUKA HOLDINGS CO., LTD. 451
20.1.8.1 Business overview 451
20.1.8.2 Products/Solutions/Services offered 452
20.1.8.3 Recent developments 453
20.1.8.3.1 Product launches 453
20.1.8.3.2 Expansions 454
20.1.8.4 MnM view 454
20.1.8.4.1 Key strengths 454
20.1.8.4.2 Strategic choices 454
20.1.8.4.3 Weaknesses and competitive threats 455
20.1.9 PHARMACARE LABORATORIES 456
20.1.9.1 Business overview 456
20.1.9.2 Products/Solutions/Services offered 456
20.1.9.3 Recent developments 457
20.1.9.3.1 Expansions 457
20.1.9.4 MnM view 458
20.1.10 SWANSON 459
20.1.10.1 Business overview 459
20.1.10.2 Products/Solutions/Services offered 459
20.1.10.3 Recent developments 460
20.1.10.3.1 Product launches 460
20.1.10.4 MnM view 460
20.1.11 IM HEALTHCARE 461
20.1.11.1 Business overview 461
20.1.11.2 Products/Solutions/Services offered 461
20.1.11.3 Recent developments 462
20.1.11.4 MnM view 462
20.1.12 SMP NUTRA 463
20.1.12.1 Business overview 463
20.1.12.2 Products/Solutions/Services offered 463
20.1.12.3 Recent developments 464
20.1.12.4 MnM view 464
20.1.13 NATURE’S TRUTH 465
20.1.13.1 Business overview 465
20.1.13.2 Products/Solutions/Services offered 465
20.1.13.3 Recent developments 466
20.1.13.3.1 Other developments 466
20.1.13.4 MnM view 466
20.1.14 HERBALAND NATURALS INC. 467
20.1.14.1 Business overview 467
20.1.14.2 Products/Solutions/Services offered 467

20.1.14.3 Recent developments 468
20.1.14.4 MnM view 468
20.1.15 BOSCOGEN, INC. 469
20.1.15.1 Business overview 469
20.1.15.2 Products/Solutions/Services offered 469
20.1.15.3 Recent developments 469
20.1.15.4 MnM view 469
20.2 B2B PLAYERS (CONTRACT MANUFACTURERS) 470
20.2.1 SOFGEN PHARMA 470
20.2.1.1 Business overview 470
20.2.1.2 Products/Services/Solutions offered 471
20.2.1.3 Recent developments 472
20.2.1.3.1 Expansions 472
20.2.1.4 MnM view 473
20.2.1.4.1 Key strengths 473
20.2.1.4.2 Strategic choices 473
20.2.1.4.3 Weaknesses & competitive threats 473
20.2.2 CATALENT, INC. 474
20.2.2.1 Business overview 474
20.2.2.2 Products/Services/Solutions offered 474
20.2.2.3 Recent developments 475
20.2.2.3.1 Deals 475
20.2.2.4 MnM view 475
20.2.2.4.1 Key strengths 475
20.2.2.4.2 Strategic choices 475
20.2.2.4.3 Weaknesses & competitive threats 475
20.2.3 ACTIV’INSIDE 476
20.2.3.1 Business overview 476
20.2.3.2 Products/Services/Solutions offered 476
20.2.3.3 Recent developments 477
20.2.3.4 MnM view 477
20.2.3.4.1 Key strengths 477
20.2.3.4.2 Strategic choices 477
20.2.3.4.3 Weaknesses & competitive threats 477
20.2.4 SIRIO PHARMA CO., LTD. 478
20.2.4.1 Business overview 478
20.2.4.2 Products/Services/Solutions offered 479
20.2.4.3 Recent developments 480
20.2.4.3.1 Product launches 480
20.2.4.4 MnM view 480

20.2.5 WIN NUTRA 481
20.2.5.1 Business overview 481
20.2.5.2 Products/Services/Solutions offered 481
20.2.5.3 Recent developments 482
20.2.5.4 MnM view 482
20.2.6 MAKERS NUTRITION, LLC 483
20.2.6.1 Business overview 483
20.2.6.2 Products/Services/Solutions offered 484
20.2.6.3 Recent developments 485
20.2.6.4 MnM view 485
20.2.7 ION LABS 486
20.2.7.1 Business overview 486
20.2.7.2 Products/Services/Solutions offered 487
20.2.7.3 Recent developments 487
20.2.7.3.1 Expansions 487
20.2.7.3.2 Deals 488
20.2.7.4 MnM view 488
20.2.8 VITAJOY GROUP 489
20.2.8.1 Business overview 489
20.2.8.2 Products/Services/Solutions offered 490
20.2.8.3 Recent developments 490
20.2.8.4 MnM view 490
20.2.9 BLISS LIFESCIENCES LLP 491
20.2.9.1 Business overview 491
20.2.9.2 Products/Services/Solutions offered 491
20.2.9.3 Recent developments 492
20.2.9.4 MnM view 492
20.2.10 GLOBAL WIDGET 493
20.2.10.1 Business overview 493
20.2.10.2 Products/Services/Solutions offered 494
20.2.10.3 Recent developments 495
20.2.10.3.1 Product launches 495
20.2.10.3.2 Deals 496
20.2.10.3.3 Expansions 496
20.2.10.4 MnM view 496
20.2.11 GUMMY WORLDS 497
20.2.12 TOPGUM 498
20.2.13 MERICAL 499
20.2.14 FERMENTIS LIFE SCIENCES 500
20.2.15 EAGLE LABS, INC. 501

21 RESEARCH METHODOLOGY 502
21.1 RESEARCH DATA 502
21.1.1 SECONDARY DATA 503
21.1.1.1 Key data from secondary sources 503
21.1.2 PRIMARY DATA 504
21.1.2.1 Key industry insights 504
21.1.2.2 Breakdown of primary interviews 505
21.1.2.3 Primary sources 505
21.2 MARKET SIZE ESTIMATION 506
21.2.1 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: SUPPLY SIDE 507
21.2.2 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: DEMAND SIDE 507
21.2.3 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 508
21.2.4 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 510
21.3 DATA TRIANGULATION 511
21.4 RESEARCH ASSUMPTIONS 512
21.5 RESEARCH LIMITATIONS 512
22 ADJACENT & RELATED MARKETS 513
22.1 INTRODUCTION 513
22.2 LIMITATIONS 513
22.3 NUTRACEUTICAL INGREDIENTS MARKET 514
22.3.1 MARKET DEFINITION 514
22.3.2 MARKET OVERVIEW 514
22.4 DIETARY SUPPLEMENTS MARKET 515
22.4.1 MARKET DEFINITION 515
22.4.2 MARKET OVERVIEW 515
23 APPENDIX 517
23.1 DISCUSSION GUIDE 517
23.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 525
23.3 CUSTOMIZATION OPTIONS 527
23.4 RELATED REPORTS 527
23.5 AUTHOR DETAILS 528

LIST OF TABLES

TABLE 1 USD EXCHANGE RATES, 2020–2024 53
TABLE 2 IMPACT OF PORTER’S FIVE FORCES NUTRACEUTICAL GUMMIES MARKET 81
TABLE 3 NUTRACEUTICAL GUMMIES MARKET: SUPPLY CHAIN (ECOSYSTEM) 91
TABLE 4 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER, 2023 (USD/UNIT) 92
TABLE 5 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021–2024 (USD/TON) 95
TABLE 6 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2024 97
TABLE 7 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2023 97
TABLE 8 NUTRACEUTICAL GUMMIES MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 98
TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES 103
TABLE 10 PATENTS PERTAINING TO NUTRACEUTICAL GUMMIES, 2019–2025 113
TABLE 11 TOP USE CASES AND MARKET POTENTIAL 118
TABLE 12 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 119
TABLE 13 NUTRACEUTICAL GUMMIES MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 119
TABLE 14 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 120
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 18 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 19 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 20 GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL GUMMIES MARKET 124
TABLE 21 LABELING REQUIREMENTS AND CLAIMS IN NUTRACEUTICAL GUMMIES MARKET 124
TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN NUTRACEUTICAL GUMMIES MARKET 128
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES 131
TABLE 24 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 131
TABLE 25 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET, BY KEY INDUSTRIES ACROSS SUPPLY CHAIN 133
TABLE 26 COST DYNAMICS IN NUTRACEUTICAL GUMMIES MARKET 135
TABLE 27 MARGIN OPPORTUNITIES IN NUTRACEUTICAL GUMMIES MARKET, BY TYPE 136
TABLE 28 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION) 138
TABLE 29 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION) 138
TABLE 30 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (TONS) 138
TABLE 31 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (TONS) 138
TABLE 32 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 141
TABLE 33 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 142
TABLE 34 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 144
TABLE 35 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 145
TABLE 36 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 146
TABLE 37 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 147
TABLE 38 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 149
TABLE 39 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 149
TABLE 40 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 151
TABLE 41 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 151
TABLE 42 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 153
TABLE 43 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 153
TABLE 44 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY,
2021–2024 (USD MILLION) 155
TABLE 45 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY,
2025–2030 (USD MILLION) 156
TABLE 46 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 157
TABLE 47 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 157
TABLE 48 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 158
TABLE 49 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 158
TABLE 50 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 159
TABLE 51 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 160
TABLE 52 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE,
2021–2024 (USD MILLION) 163
TABLE 53 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE,
2025–2030 (USD MILLION) 163
TABLE 54 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 164
TABLE 55 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 165
TABLE 56 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 166
TABLE 57 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 167
TABLE 58 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 168
TABLE 59 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 169
TABLE 60 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 170
TABLE 61 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 171
TABLE 62 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS,
2021–2024 (USD MILLION) 174
TABLE 63 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS,
2025–2030 (USD MILLION) 174
TABLE 64 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 175
TABLE 65 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 175
TABLE 66 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 176
TABLE 67 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 176
TABLE 68 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 177
TABLE 69 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 177
TABLE 70 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 178
TABLE 71 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 178
TABLE 72 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 181
TABLE 73 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 181
TABLE 74 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2021–2024 (USD MILLION) 182
TABLE 75 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2025–2030 (USD MILLION) 182
TABLE 76 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 182
TABLE 77 VITAMIN GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 183
TABLE 78 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 183
TABLE 79 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 184
TABLE 80 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 184
TABLE 81 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 185
TABLE 82 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 185
TABLE 83 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 186
TABLE 84 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 187
TABLE 85 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 187
TABLE 86 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 188
TABLE 87 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 188
TABLE 88 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2021–2024 (USD MILLION) 189
TABLE 89 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2025–2030 (USD MILLION) 190
TABLE 90 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 190
TABLE 91 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 190
TABLE 92 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 191
TABLE 93 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 191
TABLE 94 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 192
TABLE 95 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 192
TABLE 96 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 192
TABLE 97 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 193
TABLE 98 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 193
TABLE 99 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 194
TABLE 100 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 195
TABLE 101 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 196
TABLE 102 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 197
TABLE 103 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 197
TABLE 104 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2021–2024 (USD MILLION) 198
TABLE 105 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2025–2030 (USD MILLION) 199
TABLE 106 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION) 199
TABLE 107 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION) 200
TABLE 108 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 200
TABLE 109 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 200
TABLE 110 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 201
TABLE 111 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 201
TABLE 112 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 202
TABLE 113 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 202
TABLE 114 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 203
TABLE 115 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 203
TABLE 116 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 204
TABLE 117 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 204
TABLE 118 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 205
TABLE 119 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 205
TABLE 120 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 206
TABLE 121 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 206
TABLE 122 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 207
TABLE 123 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 207
TABLE 124 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 208
TABLE 125 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 208
TABLE 126 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024
(USD MILLION) 210
TABLE 127 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030
(USD MILLION) 211
TABLE 128 IMMUNITY SUPPORT: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 211
TABLE 129 IMMUNITY SUPPORT GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 212
TABLE 130 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 213
TABLE 131 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 213
TABLE 132 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 214
TABLE 133 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 214
TABLE 134 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 215
TABLE 135 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 216
TABLE 136 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 216
TABLE 137 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 217
TABLE 138 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 217
TABLE 139 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 218
TABLE 140 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2021–2024 (USD MILLION) 221
TABLE 141 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2025–2030 (USD MILLION) 221
TABLE 142 GENERATION ALPHA (0–12 YEARS): NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2021–2024 (USD MILLION) 222
TABLE 143 GENERATION ALPHA (0–12 YEARS): NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2025–2030 (USD MILLION) 222
TABLE 144 GENERATION Z (13–28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 223
TABLE 145 GENERATION Z (13–28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 223
TABLE 146 MILLENNIALS (29–44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 224
TABLE 147 MILLENNIALS (29–44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 225
TABLE 148 GENERATION X (45–60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 225
TABLE 149 GENERATION X (45–60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 226
TABLE 150 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 227
TABLE 151 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 227
TABLE 152 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL,
2021–2024 (USD MILLION) 229
TABLE 153 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL,
2025–2030 (USD MILLION) 230
TABLE 154 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 230
TABLE 155 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 231
TABLE 156 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2021–2024 (USD MILLION) 231
TABLE 157 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE,
2025–2030 (USD MILLION) 231
TABLE 158 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2021–2024 (USD MILLION) 232
TABLE 159 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET,
BY REGION, 2025–2030 (USD MILLION) 232
TABLE 160 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 233
TABLE 161 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 233
TABLE 162 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 234
TABLE 163 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 234
TABLE 164 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 235
TABLE 165 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 235
TABLE 166 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 236
TABLE 167 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 236
TABLE 168 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2021–2024 (USD MILLION) 237
TABLE 169 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION,
2025–2030 (USD MILLION) 238
TABLE 170 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 241
TABLE 171 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 242
TABLE 172 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 242
TABLE 173 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 242
TABLE 174 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 243
TABLE 175 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 243
TABLE 176 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 243
TABLE 177 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 244
TABLE 178 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 245
TABLE 179 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 246
TABLE 180 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 246
TABLE 181 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 246
TABLE 182 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 246
TABLE 183 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 247
TABLE 184 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 247
TABLE 185 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 247
TABLE 186 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 248
TABLE 187 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 248
TABLE 188 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 248
TABLE 189 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 249
TABLE 190 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 249
TABLE 191 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 249
TABLE 192 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 250
TABLE 193 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 250
TABLE 194 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 250
TABLE 195 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 251
TABLE 196 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 251
TABLE 197 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 251
TABLE 198 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 252
TABLE 199 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 252
TABLE 200 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 252
TABLE 201 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 253
TABLE 202 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 253
TABLE 203 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 254
TABLE 204 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 254
TABLE 205 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 255
TABLE 206 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (USD MILLION) 255
TABLE 207 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (USD MILLION) 255
TABLE 208 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (TONS) 256
TABLE 209 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (TONS) 256
TABLE 210 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 256
TABLE 211 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 257
TABLE 212 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 257
TABLE 213 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 257
TABLE 214 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (USD MILLION) 258
TABLE 215 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (USD MILLION) 258
TABLE 216 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (TONS) 258
TABLE 217 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (TONS) 259
TABLE 218 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 259
TABLE 219 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 259
TABLE 220 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 259
TABLE 221 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 260
TABLE 222 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 260
TABLE 223 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 260
TABLE 224 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 261
TABLE 225 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 261
TABLE 226 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 261
TABLE 227 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 262
TABLE 228 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 262
TABLE 229 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 262
TABLE 230 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 263
TABLE 231 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 263
TABLE 232 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 263
TABLE 233 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 264
TABLE 234 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 265
TABLE 235 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 265
TABLE 236 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 266
TABLE 237 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 266
TABLE 238 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 268
TABLE 239 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 268
TABLE 240 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 268
TABLE 241 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 269
TABLE 242 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 270
TABLE 243 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 270
TABLE 244 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 270
TABLE 245 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 271
TABLE 246 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 272
TABLE 247 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 272
TABLE 248 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 272
TABLE 249 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 273
TABLE 250 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 273
TABLE 251 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 273
TABLE 252 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 274
TABLE 253 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 274
TABLE 254 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 274
TABLE 255 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 275
TABLE 256 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 275
TABLE 257 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 275
TABLE 258 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 276
TABLE 259 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 276
TABLE 260 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (TONS) 276
TABLE 261 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (TONS) 277
TABLE 262 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 277
TABLE 263 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 277
TABLE 264 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 278
TABLE 265 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 278
TABLE 266 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 278
TABLE 267 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 279
TABLE 268 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 279
TABLE 269 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 279
TABLE 270 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 280
TABLE 271 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 280
TABLE 272 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (TONS) 281
TABLE 273 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (TONS) 281
TABLE 274 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (USD MILLION) 282
TABLE 275 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (USD MILLION) 282
TABLE 276 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (TONS) 282
TABLE 277 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (TONS) 283
TABLE 278 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 283
TABLE 279 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 283
TABLE 280 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 284
TABLE 281 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 284
TABLE 282 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (USD MILLION) 284
TABLE 283 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (USD MILLION) 285
TABLE 284 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (TONS) 285
TABLE 285 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (TONS) 285
TABLE 286 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 286
TABLE 287 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 286
TABLE 288 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 286
TABLE 289 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 286
TABLE 290 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 287
TABLE 291 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 287
TABLE 292 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 287
TABLE 293 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 288
TABLE 294 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2021–2024 (USD MILLION) 288
TABLE 295 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2025–2030 (USD MILLION) 288
TABLE 296 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2021–2024 (TONS) 289
TABLE 297 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS,
2025–2030 (TONS) 289
TABLE 298 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2021–2024 (USD MILLION) 289
TABLE 299 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2025–2030 (USD MILLION) 290
TABLE 300 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2021–2024 (TONS) 290
TABLE 301 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY,
2025–2030 (TONS) 290
TABLE 302 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 292
TABLE 303 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 292
TABLE 304 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 292
TABLE 305 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 293
TABLE 306 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 294
TABLE 307 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 294
TABLE 308 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 295
TABLE 309 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 295
TABLE 310 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 297
TABLE 311 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 297
TABLE 312 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 297
TABLE 313 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 298
TABLE 314 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 299
TABLE 315 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 299
TABLE 316 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 300
TABLE 317 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 300
TABLE 318 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 302
TABLE 319 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 302
TABLE 320 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 302
TABLE 321 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 303
TABLE 322 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 304
TABLE 323 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 304
TABLE 324 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 304
TABLE 325 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 305
TABLE 326 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 306
TABLE 327 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 307
TABLE 328 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 307
TABLE 329 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 307
TABLE 330 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 308
TABLE 331 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 308
TABLE 332 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 308
TABLE 333 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 309
TABLE 334 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 309
TABLE 335 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 309
TABLE 336 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 310
TABLE 337 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 310
TABLE 338 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 310
TABLE 339 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 311
TABLE 340 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 311
TABLE 341 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 311
TABLE 342 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 312
TABLE 343 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 312
TABLE 344 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 312
TABLE 345 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 313
TABLE 346 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 313
TABLE 347 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 313
TABLE 348 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 314
TABLE 349 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 314
TABLE 350 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 314
TABLE 351 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 315
TABLE 352 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 315
TABLE 353 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 316
TABLE 354 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (USD MILLION) 316
TABLE 355 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (USD MILLION) 316
TABLE 356 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (TONS) 317
TABLE 357 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (TONS) 317
TABLE 358 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 317
TABLE 359 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 318
TABLE 360 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 318
TABLE 361 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 318
TABLE 362 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (USD MILLION) 319
TABLE 363 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (USD MILLION) 319
TABLE 364 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (TONS) 319
TABLE 365 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (TONS) 320
TABLE 366 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 320
TABLE 367 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 320
TABLE 368 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 320
TABLE 369 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 321
TABLE 370 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 321
TABLE 371 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 321
TABLE 372 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 322
TABLE 373 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 322
TABLE 374 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 322
TABLE 375 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 323
TABLE 376 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 323
TABLE 377 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 323
TABLE 378 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 324
TABLE 379 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 324
TABLE 380 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 324
TABLE 381 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 325
TABLE 382 CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 326
TABLE 383 CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 326
TABLE 384 CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 327
TABLE 385 CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 327
TABLE 386 JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 329
TABLE 387 JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 329
TABLE 388 JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 329
TABLE 389 JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 330
TABLE 390 INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 331
TABLE 391 INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 331
TABLE 392 INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 332
TABLE 393 INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 332
TABLE 394 AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET,
BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 334
TABLE 395 AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET,
BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 334
TABLE 396 AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET,
BY PRODUCT TYPE, 2021–2024 (USD MILLION) 335
TABLE 397 AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET,
BY PRODUCT TYPE, 2025–2030 (USD MILLION) 335
TABLE 398 REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 336
TABLE 399 REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 337
TABLE 400 REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 337
TABLE 401 REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 338
TABLE 402 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 339
TABLE 403 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 339
TABLE 404 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 339
TABLE 405 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 340
TABLE 406 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 340
TABLE 407 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 340
TABLE 408 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2021–2024 (TONS) 340
TABLE 409 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY,
2025–2030 (TONS) 341
TABLE 410 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 341
TABLE 411 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 341
TABLE 412 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 342
TABLE 413 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 342
TABLE 414 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 342
TABLE 415 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 343
TABLE 416 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 343
TABLE 417 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 343
TABLE 418 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 344
TABLE 419 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 344
TABLE 420 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 344
TABLE 421 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 345
TABLE 422 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 345
TABLE 423 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 345
TABLE 424 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 346
TABLE 425 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 346
TABLE 426 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 346
TABLE 427 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 347
TABLE 428 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 347
TABLE 429 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 348
TABLE 430 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (USD MILLION) 348
TABLE 431 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (USD MILLION) 348
TABLE 432 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2021–2024 (TONS) 349
TABLE 433 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN,
2025–2030 (TONS) 349
TABLE 434 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL
& BOTANICAL, 2021–2024 (USD MILLION) 349
TABLE 435 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL
& BOTANICAL, 2025–2030 (USD MILLION) 350
TABLE 436 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL
& BOTANICAL, 2021–2024 (TONS) 350
TABLE 437 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL
& BOTANICAL, 2025–2030 (TONS) 350
TABLE 438 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (USD MILLION) 351
TABLE 439 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (USD MILLION) 351
TABLE 440 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2021–2024 (TONS) 351
TABLE 441 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL,
2025–2030 (TONS) 352
TABLE 442 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 352
TABLE 443 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 352
TABLE 444 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 352
TABLE 445 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 353
TABLE 446 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 353
TABLE 447 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 353
TABLE 448 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 354
TABLE 449 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 354
TABLE 450 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 354
TABLE 451 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 355
TABLE 452 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 355
TABLE 453 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 355
TABLE 454 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 356
TABLE 455 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 356
TABLE 456 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 356
TABLE 457 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 357
TABLE 458 BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 358
TABLE 459 BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 358
TABLE 460 BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 359
TABLE 461 BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 359
TABLE 462 ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 360
TABLE 463 ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 361
TABLE 464 ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 361
TABLE 465 ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 362
TABLE 466 REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET,
BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 363
TABLE 467 REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET,
BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 363
TABLE 468 REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 363
TABLE 469 REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 364
TABLE 470 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 364
TABLE 471 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 365
TABLE 472 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 365
TABLE 473 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 365
TABLE 474 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 365
TABLE 475 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 366
TABLE 476 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 366
TABLE 477 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 366
TABLE 478 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 366
TABLE 479 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 367
TABLE 480 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 367
TABLE 481 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 367
TABLE 482 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 368
TABLE 483 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 368
TABLE 484 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 368
TABLE 485 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 369
TABLE 486 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 369
TABLE 487 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 369
TABLE 488 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 370
TABLE 489 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 370
TABLE 490 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 370
TABLE 491 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 371
TABLE 492 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 371
TABLE 493 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 371
TABLE 494 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 372
TABLE 495 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 372
TABLE 496 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 373
TABLE 497 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 373
TABLE 498 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION) 374
TABLE 499 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION) 374
TABLE 500 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS) 374
TABLE 501 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS) 375
TABLE 502 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 375
TABLE 503 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 375
TABLE 504 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 376
TABLE 505 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 376
TABLE 506 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION) 376
TABLE 507 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION) 377
TABLE 508 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS) 377
TABLE 509 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS) 377
TABLE 510 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 378
TABLE 511 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 378
TABLE 512 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 378
TABLE 513 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 378
TABLE 514 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 379
TABLE 515 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 379
TABLE 516 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 379
TABLE 517 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 380
TABLE 518 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 380
TABLE 519 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 380
TABLE 520 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY DEMOGRAPHICS, 2021–2024 (TONS) 381
TABLE 521 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY DEMOGRAPHICS, 2025–2030 (TONS) 381
TABLE 522 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY FUNCTIONALITY, 2021–2024 (USD MILLION) 381
TABLE 523 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY FUNCTIONALITY, 2025–2030 (USD MILLION) 382
TABLE 524 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY FUNCTIONALITY, 2021–2024 (TONS) 382
TABLE 525 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET,
BY FUNCTIONALITY, 2025–2030 (TONS) 382
TABLE 526 MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 384
TABLE 527 MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 384
TABLE 528 MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 385
TABLE 529 MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 385
TABLE 530 AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2021–2024 (USD MILLION) 386
TABLE 531 AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE,
2025–2030 (USD MILLION) 387
TABLE 532 AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2021–2024 (USD MILLION) 387
TABLE 533 AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE,
2025–2030 (USD MILLION) 388
TABLE 534 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL GUMMIES MARKET, 2020–2025 390
TABLE 535 B2C NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024 393
TABLE 536 B2B NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024 395
TABLE 537 B2C NUTRACEUTICAL GUMMIES MARKET: REGIONAL FOOTPRINT 401
TABLE 538 B2C NUTRACEUTICAL GUMMIES MARKET: PRODUCT TYPE FOOTPRINT 402
TABLE 539 B2C NUTRACEUTICAL GUMMIES MARKET: FUNCTIONALITY FOOTPRINT 403
TABLE 541 NUTRACEUTICAL GUMMIES MARKET: COMPETITIVE BENCHMARKING OF
B2B COMPANIES 407
TABLE 542 NUTRACEUTICAL GUMMIES MARKET: PRODUCT LAUNCHES, 2020–
OCTOBER 2025 409
TABLE 543 NUTRACEUTICAL GUMMIES MARKET: DEALS, 2020–OCTOBER 2025 413
TABLE 544 NUTRACEUTICAL GUMMIES MARKET: EXPANSIONS, 2020–OCTOBER 2025 416
TABLE 545 NUTRACEUTICAL GUMMIES MARKET: OTHER DEVELOPMENTS, 2020–
OCTOBER 2025 418
TABLE 546 CHURCH & DWIGHT CO., INC.: COMPANY OVERVIEW 419
TABLE 547 CHURCH & DWIGHT CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 420
TABLE 548 CHURCH & DWIGHT CO., INC.: PRODUCT LAUNCHES 421
TABLE 549 H&H GROUP: COMPANY OVERVIEW 423
TABLE 550 H&H GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 424
TABLE 551 H&H GROUP: DEALS 425
TABLE 552 H&H GROUP: EXPANSIONS 426
TABLE 553 H&H GROUP: OTHER DEVELOPMENTS 426
TABLE 554 AMWAY: COMPANY OVERVIEW 428
TABLE 555 AMWAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 429
TABLE 556 AMWAY: PRODUCT LAUNCHES 430
TABLE 557 AMWAY: DEALS 431
TABLE 558 BAYER AG: COMPANY OVERVIEW 432
TABLE 559 BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 433
TABLE 560 BAYER AG: PRODUCT LAUNCHES 435
TABLE 561 HALEON GROUP OF COMPANIES: COMPANY OVERVIEW 436
TABLE 562 HALEON GROUP OF COMPANIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 437
TABLE 563 HALEON GROUP OF COMPANIES: PRODUCT LAUNCHES 439
TABLE 564 HALEON GROUP OF COMPANIES: DEALS 440
TABLE 565 HALEON GROUP OF COMPANIES: EXPANSIONS 440
TABLE 566 NESTLE: COMPANY OVERVIEW 442
TABLE 567 NESTLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 443
TABLE 568 NESTLE: PRODUCT LAUNCHES 445
TABLE 569 NESTLE: DEALS 445
TABLE 570 UNILEVER: COMPANY OVERVIEW 447
TABLE 571 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 448
TABLE 572 UNILEVER: PRODUCT LAUNCHES 449
TABLE 573 UNILEVER: DEALS 449
TABLE 574 UNILEVER: EXPANSIONS 450
TABLE 575 OTSUKA HOLDINGS CO., LTD.: COMPANY OVERVIEW 451
TABLE 576 OTSUKA HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 452
TABLE 577 OTSUKA HOLDINGS CO., LTD.: PRODUCT LAUNCHES 453
TABLE 578 OTSUKA HOLDINGS CO., LTD.: EXPANSIONS 454
TABLE 579 PHARMACARE LABORATORIES: COMPANY OVERVIEW 456
TABLE 580 PHARMACARE LABORATORIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 456
TABLE 581 PHARMACARE LABORATORIES: EXPANSIONS 457
TABLE 582 SWANSON: COMPANY OVERVIEW 459
TABLE 583 SWANSON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 459
TABLE 584 SWANSON: PRODUCT LAUNCHES 460
TABLE 585 IM HEALTHCARE: COMPANY OVERVIEW 461
TABLE 586 IM HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 461
TABLE 587 SMP NUTRA: COMPANY OVERVIEW 463
TABLE 588 SMP NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 463
TABLE 589 NATURE’S TRUTH: COMPANY OVERVIEW 465
TABLE 590 NATURE’S TRUTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 465
TABLE 591 NATURE’S TRUTH: OTHER DEVELOPMENTS 466
TABLE 592 HERBALAND NATURALS INC.: COMPANY OVERVIEW 467
TABLE 593 HERBALAND NATURALS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 467
TABLE 594 BOSCOGEN, INC.: COMPANY OVERVIEW 469
TABLE 595 BOSCOGEN, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 469
TABLE 596 SOFGEN PHARMA: COMPANY OVERVIEW 470
TABLE 597 SOFGEN PHARMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 471
TABLE 598 SOFGEN PHARMA: EXPANSIONS 472
TABLE 599 CATALENT, INC.: COMPANY OVERVIEW 474
TABLE 600 CATALENT, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 474
TABLE 601 CATALENT, INC.: DEALS 475
TABLE 602 ACTIV’INSIDE: COMPANY OVERVIEW 476
TABLE 603 ACTIV’INSIDE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 476
TABLE 604 SIRIO PHARMA CO., LTD.: COMPANY OVERVIEW 478
TABLE 605 SIRIO PHARMA CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 479
TABLE 606 SIRIO PHARMA CO., LTD.: PRODUCT LAUNCHES 480
TABLE 607 WIN NUTRA: COMPANY OVERVIEW 481
TABLE 608 WIN NUTRA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 481
TABLE 609 MAKERS NUTRITION, LLC.: COMPANY OVERVIEW 483
TABLE 610 MAKERS NUTRITION, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 484
TABLE 611 ION LABS: COMPANY OVERVIEW 486
TABLE 612 ION LABS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 487
TABLE 613 ION LABS: EXPANSIONS 487
TABLE 614 ION LABS: DEALS 488
TABLE 615 VITAJOY GROUP: COMPANY OVERVIEW 489
TABLE 616 VITAJOY GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 490
TABLE 617 BLISS LIFESCIENCES LLP: COMPANY OVERVIEW 491
TABLE 618 BLISS LIFESCIENCES LLP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 491
TABLE 619 GLOBAL WIDGET: COMPANY OVERVIEW 493
TABLE 620 GLOBAL WIDGET: PRODUCTS/SERVICES/SOLUTIONS OFFERED 494
TABLE 621 GLOBAL WIDGET: PRODUCT LAUNCHES 495
TABLE 622 GLOBAL WIDGET: DEALS 496
TABLE 623 GLOBAL WIDGET: EXPANSIONS 496
TABLE 624 ADJACENT MARKETS TO NUTRACEUTICAL GUMMIES MARKET 513
TABLE 625 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 514
TABLE 626 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 515
TABLE 627 DIETARY SUPPLEMENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 516
TABLE 628 DIETARY SUPPLEMENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 516

LIST OF FIGURES

FIGURE 1 NUTRACEUTICAL GUMMIES MARKET SEGMENTATION 52
FIGURE 2 YEARS CONSIDERED 53
FIGURE 3 MARKET SCENARIO 55
FIGURE 4 B2C NUTRACEUTICAL GUMMIES MARKET, 2021–2030 56
FIGURE 5 B2B NUTRACEUTICAL GUMMIES MARKET, 2021-2030 56
FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN B2C NUTRACEUTICAL GUMMIES MARKET (2020–2025) 57
FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF NUTRACEUTICAL GUMMIES MARKET 58
FIGURE 8 HIGH-GROWTH SEGMENTS IN B2C NUTRACEUTICAL GUMMIES MARKET 59
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN B2C NUTRACEUTICAL GUMMIES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 60
FIGURE 10 FOCUS ON CONTRACT MANUFACTURING, SCALE EFFICIENCY, AND INGREDIENT AVAILABILITY TO DRIVE B2B NUTRACEUTICAL GUMMIES MARKET 61
FIGURE 11 RISING CONSUMER PREFERENCE FOR CONVENIENT, FUNCTIONAL, AND PALATABLE SUPPLEMENTS TO DRIVE B2C NUTRACEUTICAL GUMMIES MARKET 61
FIGURE 12 MID-SCALE MANUFACTURERS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025 62
FIGURE 13 VITAMINS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST
MARKET SHARES IN 2025 63
FIGURE 14 BRAND OWNERS & MARKETING COMPANIES SEGMENT TO DOMINATE
MARKET IN 2025 63
FIGURE 15 ANIMAL-BASED SOURCES SEGMENT TO LEAD MARKET IN 2025 64
FIGURE 16 GENERATION Z SEGMENT TO LEAD MARKET IN 2025 64
FIGURE 17 US TO DOMINATE MARKET IN 2025 65
FIGURE 18 US TO DOMINATE MARKET IN 2025 65
FIGURE 19 NUTRACEUTICAL GUMMIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
FIGURE 20 NUTRACEUTICAL GUMMIES MARKET: PORTER’S FIVE FORCES ANALYSIS 81
FIGURE 21 NUTRACEUTICAL GUMMIES (B2B & B2C) MARKET: VALUE CHAIN ANALYSIS 87
FIGURE 22 NUTRACEUTICAL GUMMIES MARKET: ECOSYSTEM ANALYSIS 90
FIGURE 23 AVERAGE SELLING PRICE OF MARKET PLAYERS, BY PRODUCT TYPES,
2024 (USD/TON) 92
FIGURE 24 AVERAGE SELLING PRICE TREND OF NUTRACEUTICAL GUMMIES,
BY REGION, 2021–2024 (USD/TON) 95
FIGURE 25 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT) 96
FIGURE 26 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT) 96
FIGURE 27 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 99
FIGURE 28 INVESTMENT AND FUNDING SCENARIO 99
FIGURE 29 NUMBER OF PATENTS GRANTED BETWEEN 2015 AND 2025 112
FIGURE 30 FUTURE APPLICATIONS 114
FIGURE 31 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 118
FIGURE 32 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 120
FIGURE 33 NUTRACEUTICAL GUMMIES MARKET DECISION-MAKING FACTORS 129
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES 130
FIGURE 35 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 131
FIGURE 36 ADOPTION BARRIERS AND INTERNAL CHALLENGES 132
FIGURE 37 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025 VS.
2030 (USD MILLION) 141
FIGURE 38 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY,
2025 VS. 2030 (USD MILLION) 155
FIGURE 39 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE,
2025 VS. 2030 (USD MILLION) 162
FIGURE 40 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS,
2025 VS. 2030 (USD MILLION) 173
FIGURE 48 REVENUE ANALYSIS OF B2C MARKET PLAYERS, 2022–2024 (USD MILLION) 391
FIGURE 49 SHARE ANALYSIS FOR B2C MARKET PLAYERS, 2024 392
FIGURE 50 SHARE ANALYSIS FOR B2B MARKET PLAYERS, 2024 395
FIGURE 51 NUTRACEUTICAL GUMMIES MARKET: BRAND/PRODUCT COMPARISON 396
FIGURE 52 NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX
(B2C COMPANIES), 2024 399
FIGURE 53 B2C NUTRACEUTICAL GUMMIES MARKET: COMPANY FOOTPRINT 400
FIGURE 54 NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX
(B2B COMPANIES), 2024 405
FIGURE 55 COMPANY VALUATION FOR MAJOR PLAYERS IN NUTRACEUTICAL
GUMMIES MARKET 408
FIGURE 56 EV/EBITDA OF MAJOR PLAYERS 409
FIGURE 57 CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT 420
FIGURE 58 H&H GROUP: COMPANY SNAPSHOT 424
FIGURE 59 AMWAY: COMPANY SNAPSHOT 428
FIGURE 60 BAYER AG: COMPANY SNAPSHOT 433
FIGURE 61 HALEON GROUP OF COMPANIES: COMPANY SNAPSHOT 437
FIGURE 62 NESTLE: COMPANY SNAPSHOT 443
FIGURE 63 UNILEVER: COMPANY SNAPSHOT 448
FIGURE 64 OTSUKA HOLDINGS CO., LTD.: COMPANY SNAPSHOT 452
FIGURE 65 SOFGEN PHARMA: COMPANY SNAPSHOT 471
FIGURE 66 SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT 479
FIGURE 67 NUTRACEUTICAL GUMMIES MARKET: RESEARCH DESIGN 502
FIGURE 68 KEY INDUSTRY INSIGHTS 504
FIGURE 69 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION,
AND REGION 505
FIGURE 70 SUPPLY-SIDE ANALYSIS 507
FIGURE 71 DEMAND-SIDE ANALYSIS 507
FIGURE 72 B2C NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH 508
FIGURE 73 B2B NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH 509
FIGURE 74 NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: TOP-DOWN APPROACH 510
FIGURE 75 DATA TRIANGULATION METHODOLOGY 511
FIGURE 76 ASSUMPTIONS 512
FIGURE 77 STUDY LIMITATIONS AND RISK ASSESSMENT 512

---

---